Insider Transactions Reported by 19 Insiders of Phathom Pharmaceuticals, Inc.

Symbol
PHAT on Nasdaq
Location
Florham Park, NJ

Insiders trading volume in the past year

Phathom Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Medicxi Ventures Management (Jersey) Ltd 10%+ Owner $60,463,034 24 Jan 2024
TAKEDA PHARMACEUTICAL CO LTD 10%+ Owner $30,420,222 24 Jan 2024
James N. Topper Director, 10%+ Owner $19,639,309 +$191,988 +0.99% 03 Jun 2025
David A. Socks Director $11,216,740 23 May 2024
Azmi Nabulsi Chief Operating Officer $10,029,637 -$51,957 -0.52% 27 Feb 2025
Steven L. Basta President and CEO, Director $5,534,319 02 Jan 2026
Sanjeev Narula Chief Financial & Bus. Officer $3,439,266 02 Jan 2026
Terrie Curran President and Chief Executive, Director $2,399,933 -$125,884 -5% 27 Feb 2025
Molly Henderson CFO and CBO $1,558,384 -$60,110 -3.7% 07 Apr 2025
Anne Marie Cook Chief Legal Off. & Corp. Sec. $1,289,632 02 Jan 2026
Asit Parikh Director $1,259,175 +$69,185 +5.8% 19 Dec 2025
Robert Charles Breedlove Principal Accounting Officer $880,441 -$12,653 -1.4% 18 Dec 2025
FRANK KARBE Director $223,425 03 Jun 2025
MICHAEL F. COLA Director $131,731 03 Jun 2025
HEIDI FIELDS Director $99,300 03 Jun 2025
Mark Stenhouse Director $99,300 03 Jun 2025
Theodore R. Schroeder Director $95,577 16 Apr 2025
Anthony J. Guzzo VP, Chief Accounting Officer $71,787 19 Jan 2022
Tadataka Yamada Director 21 May 2021

Recent Insider Transactions by Companies or Individuals for Phathom Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.